Oreola Donini

Chief Tech/Sci/R&D Officer at SOLIGENIX, INC.

Net worth: - $ as of 29/04/2024

52 year

Health Technology

Consumer Services

Oreola Donini active positions

Companies	Position	Start	End
SOLIGENIX, INC.	Chief Tech/Sci/R&D Officer	14/08/2013	-

Companies	Position	Start	End
Inimex Pharmaceuticals, Inc. Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada.	Chief Tech/Sci/R&D Officer	31/12/2006	31/12/2012
ESSA PHARMA INC.	Chief Tech/Sci/R&D Officer	31/12/2011	31/12/2012
Kinetek Pharmaceuticals, Inc.	Corporate Officer/Principal	-	-

Queen's University	Doctorate Degree
The University of California, San Francisco	Graduate Degree

International

Canada	5
United States	3

Operational

Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1
Corporate Officer/Principal	1

Sectoral

Health Technology	5
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
SOLIGENIX, INC.	Health Technology
ESSA PHARMA INC.	Health Technology

Private companies	2
Inimex Pharmaceuticals, Inc. Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada.	Health Technology
Kinetek Pharmaceuticals, Inc.	Health Technology

Private companies

Health Technology

Kinetek Pharmaceuticals, Inc.

Health Technology